Intravitreal ranibizumab for the treatment of cystoid macular edema in central retinal vein occlusion with good visual acuity by PRN, phase 2 trial.
Phase 2
Recruiting
- Conditions
- Central retinal vein occlusion
- Registration Number
- JPRN-UMIN000015826
- Lead Sponsor
- Department of ophthalmology of nihon university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Juvenile central retinal vein occlusion. Hemi central retinal vein occlusion. History of cerebral infarction or myocardial infarction. History of vitrectomy. History or presence of age-related macular degeneration or diabetic retinopathy. Previous use of subtenon injection of corticosteroids, intravitreal injection of anti-VEGF drugs or panretinal photocoaguration within 4 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ETDRS chart and the change from the baseline at 12 months after injection.
- Secondary Outcome Measures
Name Time Method